2747-04-8 Usage
Description
7-ACETOXY-4-BROMOMETHYLCOUMARIN is a chemical compound characterized as an off-white crystalline solid. It is known for its fluorescent properties, which make it a valuable reagent in various applications.
Uses
Used in Research and Diagnostic Applications:
7-ACETOXY-4-BROMOMETHYLCOUMARIN is used as a fluorescent reagent for labeling carboxylic acids. Its application reason is to facilitate the detection, analysis, and quantification of these acids in various research and diagnostic settings. The fluorescent nature of the compound allows for easier tracking and identification of the target molecules, making it a useful tool in scientific studies and medical diagnostics.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 7-ACETOXY-4-BROMOMETHYLCOUMARIN may be utilized as a starting material or intermediate in the synthesis of various drugs. Its unique chemical structure and properties can be exploited to develop new therapeutic agents or improve the efficacy of existing medications.
Used in Chemical Synthesis:
7-ACETOXY-4-BROMOMETHYLCOUMARIN can also be used in chemical synthesis for the production of other compounds with potential applications in various industries. Its versatility as a building block can lead to the development of new materials, dyes, or other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 2747-04-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,4 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2747-04:
(6*2)+(5*7)+(4*4)+(3*7)+(2*0)+(1*4)=88
88 % 10 = 8
So 2747-04-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H9BrO4/c1-7(14)16-9-2-3-10-8(6-13)4-12(15)17-11(10)5-9/h2-5H,6H2,1H3
2747-04-8Relevant articles and documents
Psoralens for pathogen inactivation
-
, (2008/06/13)
Psoralen compound compositions are synthesized which have primaryamino substitutions on the 3-, 4-, 5-, and 8- positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these psoralens result in the inactivation of pathogens which contain nucleic acid. The compounds show similar activity in test systems to 4'' and 5'' derivatives of psoralen useful for inactivation of pathogens in blood products. In addition to the psoralen compositions, the invention contemplates such inactivating methods using the new psoralens.